Last reviewed: July 9, 2026
Last updated: July 9, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide and tirzepatide are the two most prescribed GLP-1 medications for weight management, each activating different hormonal pathways in your body. While semaglutide acts on one receptor, tirzepatide engages both GLP-1 and GIP receptors, which may explain why patients using tirzepatide show an average of 20% body weight loss in clinical studies compared to 15% with semaglutide alone. PlexusDx offers both medications in injectable and oral forms, allowing you to select the option that best fits your lifestyle and health goals.
How Tirzepatide and Semaglutide Work Differently
Semaglutide activates only the GLP-1 receptor, which slows gastric emptying, reduces hunger signals in the brain, and helps regulate blood sugar levels. This single-pathway approach has proven effective for millions of patients seeking steady, sustainable weight loss. However, tirzepatide takes a dual approach by stimulating both GLP-1 and GIP receptors simultaneously, creating a more comprehensive hormonal response that amplifies appetite suppression and increases energy expenditure.
The difference in mechanism translates to clinical outcomes. In the SURMOUNT-2 trial, tirzepatide patients achieved mean weight losses of 21-22% of body weight over 72 weeks, whereas semaglutide users in comparable studies typically achieved 15-17% reductions. Both medications are compounded at licensed 503A pharmacies through PlexusDx, ensuring pharmaceutical-grade quality without requiring insurance or membership fees.
Weight Loss Results: What the Clinical Data Shows
Semaglutide has an extensive safety and efficacy record spanning multiple large trials. The STEP program demonstrated consistent weight loss across diverse patient populations, with most participants reaching their target weight within 12-16 weeks of consistent dosing. Many patients appreciate semaglutide's established track record and the availability of both injectable and oral formulations, making it flexible for different preferences.
Tirzepatide's clinical advantage lies in its greater magnitude of effect. The SURMOUNT trials showed that tirzepatide delivered significantly larger weight reductions than semaglutide at comparable timepoints, with some patients achieving 25% or greater body weight loss. For individuals seeking maximum results or those who haven't responded adequately to single-pathway therapies, tirzepatide presents a compelling option. PlexusDx offers compounded tirzepatide injections starting at $289/mo (or $249/mo on the 6-month plan)—the same flat price regardless of your current dose, so your dose may need to go up, but your price won't.
Side Effects and Tolerability: Comparing Both Medications
Both semaglutide and tirzepatide share a common side effect profile rooted in their GLP-1 mechanism: nausea, vomiting, diarrhea, and constipation occur most frequently during the first 4-8 weeks as your body adapts. These gastrointestinal effects typically resolve as treatment continues, and starting at a low dose helps minimize discomfort. Most patients report that side effects are manageable and diminish significantly after the first month.
Because tirzepatide engages an additional receptor pathway, some patients report slightly higher rates of nausea during initial titration phases; however, this does not necessarily predict long-term tolerability or efficacy. The choice between the two should factor in your medical history, current medications, and personal tolerance for gastrointestinal changes. PlexusDx's medical team can help you weigh these considerations during your initial consultation to select the medication most likely to work for your body.
Which Medication Is Right for Your Weight Loss Goal?
Semaglutide is an excellent first choice for patients new to GLP-1 therapy, those with a history of intolerance to multiple medications, or anyone seeking a single-receptor approach with a well-established safety profile spanning millions of users. It's also available in oral form through PlexusDx starting at $289 per month, offering convenience for needle-averse patients. Semaglutide injections begin at $189/mo (or $149/mo on the 6-month plan), making it the most affordable option across PlexusDx's product line.
Tirzepatide is ideal for patients seeking maximum weight loss potential, those who have plateaued on semaglutide monotherapy, or individuals with genetic variants affecting GLP-1 or GIP receptor sensitivity. PlexusDx offers the Precision Peptide Genetic Test for $99 after your first treatment month—this test analyzes key variants like GLP1R rs6923761 and GIPR rs1800437 to reveal how your genetics influence response to different peptide pathways. Understanding your genetic predisposition can help guide whether tirzepatide's dual mechanism aligns better with your physiology than semaglutide's single-pathway approach. Compounded tirzepatide injections start at $289/mo (or $249/mo on the 6-month plan), with oral tirzepatide available at $349/mo (or $279/mo on the 6-month plan).
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is tirzepatide more effective than semaglutide for everyone?
No—while tirzepatide shows larger average weight loss in clinical trials, individual results vary based on genetics, metabolism, lifestyle, and adherence. Some patients respond excellently to semaglutide and achieve their goals without needing tirzepatide. PlexusDx's Precision Peptide Genetic Test can reveal whether your genetic variants favor one medication over the other.
What does the research say about tirzepatide vs semaglutide long-term safety?
Both medications have demonstrated safety over 18-24 months of use in clinical trials. Tirzepatide's long-term data is newer since it was approved later, but early follow-up studies show sustained safety and efficacy. Rare but serious side effects—like pancreatitis or gallbladder issues—occur at similar rates in both groups and are typically managed by dose adjustment or discontinuation.
Can I switch from semaglutide to tirzepatide if I'm not seeing results?
Yes. Many patients successfully transition from semaglutide to tirzepatide after reaching a plateau or failing to achieve their target weight loss. This transition is typically made after 12-16 weeks of consistent semaglutide therapy and should be coordinated with your PlexusDx medical provider to ensure safe dose sequencing.
Does PlexusDx offer both semaglutide and tirzepatide?
Yes. PlexusDx provides compounded semaglutide injections starting at $189/mo (or $149/mo on the 6-month plan), oral semaglutide at $289/mo (or $249/mo on the 6-month plan), compounded tirzepatide injections at $289/mo (or $249/mo on the 6-month plan), and oral tirzepatide at $349/mo (or $279/mo on the 6-month plan). All medications come from licensed 503A compounding pharmacies, no insurance is required, and both are HSA/FSA eligible.
What does the Precision Peptide Genetic Test reveal about my response to semaglutide vs tirzepatide?
No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R (rs6923761), and GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is 2.5 mg Zepbound Effective for Weight Loss?
What Happens If U Stop Taking Ozempic: A Complete Guide